Back to results
US 2022/0409608 A1Published application
Dimeric naphthalimide formulations
AssigneeAlucent Biomedical, Inc.
InventorKevin S. Warner
Life of this patent
Estimating the term…
Abstract
The present disclosure provides novel formulations for dimeric naphthalimides and stability studies of the same. In some embodiments, the dimeric naphthalimide is a diacetate salt of Compound of Formula (I).
Claims71
A composition comprising:
- at least one active agent chosen from a Compound of Formula (I):
- and pharmaceutically acceptable salts thereof;
- at least one tonicity agent;
- at least one buffer;
- and
- at least one vehicle.
3 more elements
A composition chosen from one of the compositions recited in Table 1.
Dependencies are inferred from the claim text.